Pajūrio hipoterapija - Company finances
|
EUR
|
2023
From: 2023-06-15
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 13,539 | 23,168 | 19,720 |
| Profit before tax | 5,874 | -1,115 | -3,227 |
| Net profit | 5,874 | -1,115 | -3,227 |
| Equity | 5,875 | 4,761 | 1,533 |
| Liabilities | 701 | 195 | 1,429 |
| Non-current assets | 0 | 0 | 0 |
| Current assets | 6,576 | 4,956 | 2,962 |
| Total assets | 6,576 | 4,956 | 2,962 |
|
Taxes paid
|
|||
| STI taxes | 506 | 2,104 | 1,612 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +71.1% | -14.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 89.3% | -22.5% | -108.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | -23.4% | -210.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 43.4% | -4.8% | -16.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 43.4% | -4.8% | -16.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.0 | 0.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 13,539 | 23,168 | 19,720 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Pajūrio hipoterapija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-09-18 | 2023-10-05 | 1.00 |
Pajūrio hipoterapija - VMI tax arrears
As of 2026-09-17, the amount of overdue STI tax debt of the company Pajūrio hipoterapija is: 3 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-16 | 2026-09-17 | 2.79 |
| 2026-08-27 | 2026-09-02 | 2.8 |
| 2026-08-18 | 2026-08-26 | 2.44 |
| 2026-08-02 | 2026-08-10 | 2.44 |
| 2026-07-16 | 2026-08-01 | 2.14 |
| 2026-07-01 | 2026-07-07 | 2.14 |
| 2026-06-12 | 2026-06-30 | 1.74 |
| 2026-05-28 | 2026-06-05 | 1.74 |
| 2026-05-17 | 2026-05-27 | 1.14 |
| 2026-05-01 | 2026-05-16 | 1.15 |
| 2026-04-17 | 2026-04-30 | 0.83 |
| 2026-04-01 | 2026-04-08 | 0.96 |
| 2026-03-13 | 2026-03-31 | 0.8 |
| 2026-03-02 | 2026-03-11 | 0.84 |
| 2026-02-18 | 2026-03-01 | 0.6 |
| 2026-02-03 | 2026-02-16 | 1.6 |
| 2026-01-14 | 2026-02-02 | 1.4 |
| 2026-01-01 | 2026-01-05 | 1.4 |
| 2025-12-17 | 2025-12-31 | 1.12 |
| 2025-11-21 | 2025-12-08 | 1.12 |
| 2025-11-18 | 2025-11-20 | 0.76 |
| 2025-11-02 | 2025-11-09 | 0.76 |
| 2025-10-15 | 2025-11-01 | 0.65 |
| 2025-10-02 | 2025-10-18 | 0.65 |
| 2025-09-17 | 2025-10-01 | 0.37 |
| 2025-09-01 | 2025-09-08 | 0.37 |
| 2025-08-01 | 2025-08-11 | 2.41 |
| 2025-07-16 | 2025-07-31 | 2.2 |
| 2025-07-01 | 2025-07-20 | 2.42 |
| 2025-06-17 | 2025-06-30 | 1.97 |
| 2025-06-02 | 2025-06-11 | 2.01 |
| 2025-05-17 | 2025-06-01 | 1.77 |
| 2025-05-01 | 2025-05-06 | 1.77 |
| 2025-04-16 | 2025-04-30 | 1.49 |
| 2025-04-02 | 2025-04-07 | 1.49 |
| 2025-03-19 | 2025-04-01 | 1.17 |
| 2025-03-02 | 2025-03-08 | 1.17 |
| 2025-02-19 | 2025-03-01 | 0.84 |
| 2025-01-16 | 2025-02-10 | 0.84 |
| 2024-12-17 | 2024-12-31 | 0.64 |
| 2024-12-03 | 2024-12-06 | 0.64 |
| 2024-11-17 | 2024-12-02 | 0.36 |
| 2024-10-15 | 2024-10-16 | 0.12 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Pajurio hipoterapija, MB (code 306338830) is a Small partnership engaged in physiotherapy activities. In the latest financial year, 2025, revenue amounted to €19.7K, compared with €23.2K in 2024 and €13.5K in 2023, indicating a decline of 14.9% year on year but still higher than two years earlier. Profitability weakened over the period: the company reported net profit of €5.9K in 2023, then a net loss of €1.1K in 2024 and €3.2K in 2025, with the 2025 profit margin at -16.4%. The balance sheet remained small, with total assets of €3.0K in 2025, equity of €1.5K and liabilities of €1.4K. The equity ratio was 51.8% and debt-to-equity 0.93, while asset turnover stood at 6.66x. Revenue per employee was €19.7K in 2025. Overall, the company generated sales growth over two years, but 2025 showed weaker profitability and a reduced asset base.